• Fluorouracil (Adrucil) in Solid Tumor Evolution: Precision T

  2026-07-22

  Explore how Fluorouracil (5-Fluorouracil) enables advanced modeling of therapeutic heterogeneity in colon and breast cancer research. Uncover novel assay strategies grounded in recent genomic findings and learn how APExBIO's formulation advances reproducibility.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor in Redox P

  2026-07-21

  GKT137831 empowers researchers to precisely inhibit Nox1 and Nox4, dissecting reactive oxygen species dynamics in advanced models of vascular remodeling and fibrosis. Its nanomolar potency, workflow flexibility, and troubleshooting versatility make it a gold standard for translational redox research.

• Torin2: Precision mTOR Inhibitor for Advanced Cancer Researc

  2026-07-21

  Torin2 stands out as a next-generation mTOR inhibitor, offering unparalleled selectivity and potency for dissecting mTOR-driven pathways in cancer research models. Its robust performance in apoptosis assays and unique compatibility with mechanistic studies—such as those exploring active cell death signaling—enables reliable, reproducible insights that outpace legacy inhibitors.

• Berberine & Evodiamine Target TAS2R38/TRPV1 in GERD Inflamma

  2026-07-20

  This study reveals that berberine and evodiamine synergistically ameliorate gastroesophageal reflux disease (GERD) by modulating TAS2R38 and TRPV1 pathways, suppressing inflammation and restoring epithelial barrier integrity. The findings clarify the mechanistic role of bitter taste and TRPV1 receptor signaling in esophageal injury, supporting new molecular targets for GERD intervention.

• Rapamycin (Sirolimus): Protocols and Innovations for mTOR In

  2026-07-20

  Rapamycin (Sirolimus) enables high-precision modulation of mTOR signaling, driving advanced cell signaling and metabolic research. Explore optimized workflows, troubleshooting strategies, and the latest insights from autophagy and mineralization studies.

• ICAA Mitigates Cardiac Hypertrophy via RIP3/CaMKII Pathway I

  2026-07-19

  This study establishes isochlorogenic acid A (ICAA) as a direct inhibitor of RIP3, suppressing the RIP3/CaMKII pathway to alleviate angiotensin II-induced cardiac hypertrophy in vitro and in vivo. These findings introduce RIP3 as a novel therapeutic target and broaden mechanistic understanding for cardiovascular disease research.

• Lambda Protein Phosphatase: Precision Tools for Circadian Me

  2026-07-18

  Explore how Lambda Protein Phosphatase (RNase-free) empowers translational researchers to dissect the phosphorylation-dependent regulation of circadian clock proteins like BMAL1, integrating mechanistic insight with actionable guidance for protein modification validation, experimental design, and translational strategy.

• ML365: Selective TASK1 Inhibitor for Neurophysiology Researc

  2026-07-17

  ML365 (2-methoxy-N-(3-(3-methylbenzamido)phenyl)benzamide) is a potent, selective TASK1 potassium channel inhibitor used in ion channel pharmacology. It demonstrates nanomolar inhibitory activity and strong selectivity, making it valuable for neurophysiology and cardiopulmonary research. Recent evidence supports its utility in modulating neuroinflammation via NLRP3 inhibition.

• Nifedipine (BAY-a-1040): Bridging Calcium Inhibition to Tran

  2026-07-17

  Explore how Nifedipine (BAY-a-1040) enables translational breakthroughs by integrating mechanistic calcium influx inhibition with advanced modeling of metabolic adaptation. This thought-leadership article connects cutting-edge hepatic research, iron metabolism, and antifungal applications—offering actionable guidance for researchers seeking to drive clinical innovation.

• BMP4-GPX4 Axis Improves RGC Ferroptosis in Glaucoma Models

  2026-07-16

  This study demonstrates that activating BMP4-GPX4 signaling improves the survival and differentiation of retinal ganglion cells (RGCs) following retinal stem cell transplantation in a mouse glaucoma model. By mitigating ferroptosis and oxidative stress, the approach offers a new avenue for neuroprotection and functional recovery in high intraocular pressure glaucoma.

• Telmisartan in Cardiac Hypertrophy Research: Protocols & Ins

  2026-07-16

  Telmisartan, a potent angiotensin II receptor antagonist, is redefining experimental models of cardiac hypertrophy by enabling precise modulation of AT1R-driven pathways. This guide details evidence-driven workflows, highlights innovations from recent RIP3-focused studies, and provides actionable troubleshooting tips for cardiovascular disease research.

• Machine Learning Uncovers Novel Senolytics for Targeted Cell

  2026-07-15

  This study demonstrates the use of cost-effective machine learning to identify new senolytic compounds capable of selectively eliminating senescent cells. The findings pave the way for AI-driven drug discovery, with significant implications for cancer, aging, and translational research.

• Alda 1: Advanced Strategies for ALDH2 Activation in Cardiac

  2026-07-15

  Explore the unique mechanisms and research applications of Alda 1, a potent ALDH2 activator, with a focus on cardioprotection in ischemia and radiation-induced dermatitis mitigation. This article provides in-depth analysis and practical insights beyond existing guides.

• Moxidectin: Macrocyclic Lactone Anthelmintic for Antifungal

  2026-07-14

  Moxidectin is redefining antifungal research by synergizing with polyene drugs to combat Candida albicans, unlocking new therapeutic strategies beyond its established role in veterinary antiparasitic control. This guide translates the latest experimental breakthroughs into actionable workflows, troubleshooting insights, and cross-domain innovation for bench scientists.

• Radioiodinated Balsalazide Enables Ulcerative Colitis Imagin

  2026-07-14

  This study introduces a robust protocol for the radioiodination of balsalazide, establishing [125/131I]balsalazide as a highly selective radiotracer for imaging ulcerative colitis in murine models. The work addresses gaps in early-stage UC detection by demonstrating high labeling yields, tracer stability, and exceptional colonic uptake, supporting future preclinical research in inflammatory bowel disease.

413 records 8/28 page Previous Next First page 上5页 678910 下5页 Last page